MA52629A - Agents inhibiteurs de la tyrosine kinase de bruton - Google Patents
Agents inhibiteurs de la tyrosine kinase de brutonInfo
- Publication number
- MA52629A MA52629A MA052629A MA52629A MA52629A MA 52629 A MA52629 A MA 52629A MA 052629 A MA052629 A MA 052629A MA 52629 A MA52629 A MA 52629A MA 52629 A MA52629 A MA 52629A
- Authority
- MA
- Morocco
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- bruton tyrosine
- bruton
- inhibitors
- Prior art date
Links
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 title 1
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 title 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862671053P | 2018-05-14 | 2018-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52629A true MA52629A (fr) | 2021-03-24 |
Family
ID=67002348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052629A MA52629A (fr) | 2018-05-14 | 2019-05-13 | Agents inhibiteurs de la tyrosine kinase de bruton |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10899753B2 (enExample) |
| EP (1) | EP3793994B1 (enExample) |
| JP (1) | JP7359782B2 (enExample) |
| AR (1) | AR115085A1 (enExample) |
| ES (1) | ES2968222T3 (enExample) |
| MA (1) | MA52629A (enExample) |
| TW (1) | TW202016097A (enExample) |
| UY (1) | UY38233A (enExample) |
| WO (1) | WO2019222101A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11820760B2 (en) * | 2018-10-15 | 2023-11-21 | Biogen Ma Inc. | Crystalline polymorphs of Bruton's tyrosine kinase inhibitors |
| CN110627775B (zh) * | 2019-10-24 | 2026-01-30 | 特科罗生物科技(成都)有限公司 | 一种小分子化合物 |
| EP4081514A1 (en) * | 2019-12-23 | 2022-11-02 | Biogen MA Inc. | Btk inhibitors |
| CN112062691B (zh) * | 2020-06-18 | 2022-12-09 | 中国农业科学院油料作物研究所 | 一种柠檬醛苯丁酸肟酯类化合物及其合成方法和应用 |
| EP4313023A1 (en) | 2021-04-02 | 2024-02-07 | Biogen MA Inc. | Combination treatment methods of multiple sclerosis |
| KR20240128831A (ko) | 2021-12-30 | 2024-08-27 | 베이진 스위찰랜드 게엠베하 | 브루톤 티로신 키나아제(btk) 억제제와 e3 리가아제 리간드의 접합에 의한 btk의 분해 및 사용 방법 |
| JP7805983B2 (ja) | 2022-03-22 | 2026-01-26 | アッヴィ・インコーポレイテッド | ブルトン型チロシンキナーゼを分解するためのピリミジン |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| KR20140131955A (ko) | 2012-03-09 | 2014-11-14 | 카나 바이오사이언스 인코포레이션 | 신규 트리아진 유도체 |
| EP3444251B1 (en) | 2013-12-11 | 2023-06-07 | Biogen MA Inc. | Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology |
| AU2014362231B2 (en) | 2013-12-11 | 2019-04-04 | Biogen Ma Inc. | Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology |
| US20180282310A1 (en) | 2015-06-10 | 2018-10-04 | Biogen Ma Inc. | Forms and compositions of biaryl inhibitors of bruton's tyrosine kinase |
-
2019
- 2019-05-13 EP EP19732766.1A patent/EP3793994B1/en active Active
- 2019-05-13 MA MA052629A patent/MA52629A/fr unknown
- 2019-05-13 UY UY0001038233A patent/UY38233A/es not_active Application Discontinuation
- 2019-05-13 WO PCT/US2019/032018 patent/WO2019222101A1/en not_active Ceased
- 2019-05-13 ES ES19732766T patent/ES2968222T3/es active Active
- 2019-05-13 AR ARP190101270A patent/AR115085A1/es unknown
- 2019-05-13 TW TW108116422A patent/TW202016097A/zh unknown
- 2019-05-13 US US16/410,725 patent/US10899753B2/en active Active
- 2019-05-13 JP JP2020564219A patent/JP7359782B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2968222T3 (es) | 2024-05-08 |
| AR115085A1 (es) | 2020-11-25 |
| JP7359782B2 (ja) | 2023-10-11 |
| EP3793994B1 (en) | 2023-08-23 |
| TW202016097A (zh) | 2020-05-01 |
| WO2019222101A1 (en) | 2019-11-21 |
| JP2021523206A (ja) | 2021-09-02 |
| UY38233A (es) | 2019-12-31 |
| US10899753B2 (en) | 2021-01-26 |
| US20190382394A1 (en) | 2019-12-19 |
| EP3793994A1 (en) | 2021-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3873477A4 (en) | CYCLIN DEPENDENT KINASE 7 (CDK7) INHIBITOR | |
| MA53921A (fr) | Inhibiteurs de protéine tyrosine phosphatase | |
| IL286462A (en) | Protein tyrosine phosphatase inhibitors | |
| EP3844151A4 (en) | KRAS G12C INHIBITORS | |
| MA54543A (fr) | Inhibiteurs de kif18a | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| MA42623A (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| EP3414234A4 (en) | BRUTON TYROSINE KINASE HEMMER | |
| EP3710439A4 (en) | KRAS G12C INHIBITORS | |
| MA43162A (fr) | Inhibiteurs de type imidazopyrazine de tyrosine kinase de bruton | |
| EP3405192A4 (en) | BRUTON TYROSINE KINASE HEMMER | |
| MA52629A (fr) | Agents inhibiteurs de la tyrosine kinase de bruton | |
| EP3740206A4 (en) | INHIBITORS OF THE CYCLINE-DEPENDENT KINASE 7 (CDK7) | |
| EP3801503A4 (en) | INHIBITORS OF SARM1 | |
| MA42242A (fr) | Inhibiteurs de la tyrosine kinase | |
| MA41350A (fr) | Synthèse d'un inhibiteur de la tyrosine kinase de bruton | |
| EP3902805A4 (en) | CYCLINE-DEPENDENT KINASE INHIBITORS | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| EP3804707A4 (en) | KINASE INHIBITOR | |
| EP3817736A4 (en) | PIKFYVE INHIBITORS | |
| MA52809A (fr) | Inhibiteurs de sarm1 | |
| EP3962908A4 (en) | HETEROCYCLIC INHIBITORS OF TYROSINE KINASE | |
| DK3609886T3 (da) | Benzoazepinanaloger som inhiberingsmidler for bruton-tyrosinkinase | |
| MA41827A (fr) | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton | |
| ZA201906887B (en) | Bruton's tyrosine kinase inhibitors |